Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study.

Publication ,  Conference
Richardson, P; Soiffer, RJ; Antin, JH; Jin, Z; Vredenburgh, JJ; Kurtzberg, J; Martin, PL; Hockenbery, D; Steinbach, G; Murray, KF; Chen, A ...
Published in: BLOOD
November 16, 2003

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2003

Volume

102

Issue

11

Start / End Page

193A / 193A

Location

SAN DIEGO, CALIFORNIA

Publisher

AMER SOC HEMATOLOGY

Conference Name

45th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Richardson, P., Soiffer, R. J., Antin, J. H., Jin, Z., Vredenburgh, J. J., Kurtzberg, J., … Guinan, E. C. (2003). Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study. In BLOOD (Vol. 102, pp. 193A-193A). SAN DIEGO, CALIFORNIA: AMER SOC HEMATOLOGY.
Richardson, P., R. J. Soiffer, J. H. Antin, Z. Jin, J. J. Vredenburgh, J. Kurtzberg, P. L. Martin, et al. “Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study.” In BLOOD, 102:193A-193A. AMER SOC HEMATOLOGY, 2003.
Richardson P, Soiffer RJ, Antin JH, Jin Z, Vredenburgh JJ, Kurtzberg J, Martin PL, Hockenbery D, Steinbach G, Murray KF, Vogelsang GB, Chen A, Krishnan A, Prasad VK, Warren DL, Momtaz P, Batchelder A, Wei LJ, Rifai N, Bradwin G, Iacobelli M, McDonald GB, Guinan EC. Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study. BLOOD. AMER SOC HEMATOLOGY; 2003. p. 193A-193A.

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2003

Volume

102

Issue

11

Start / End Page

193A / 193A

Location

SAN DIEGO, CALIFORNIA

Publisher

AMER SOC HEMATOLOGY

Conference Name

45th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology